RARE

Conviction 0HealthcareScan · Thu, Sep 24, 2026

Ultragenyx Pharmaceutical Inc. (RARE) closed at $14.77 (-0.74%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 32, RS Rating 10, -59.6% from its 52-week high, -37.4% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

RARE$14.77-0.74%

ResistanceSupportVol 14Insider sellCongress buyCongress sell

Vol MA14 6.7M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

WSB mentions · 24h changelatest +0.00%· 1 mentions

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Ultragenyx Pharmaceutical Inc.PHARMACEUTICAL PREPARATIONSwww.ultragenyx.com ↗

Price14.77

Change-0.74%

Gap-1.01%

Rel volume0.52×

Avg volume6.74M

Avg $ vol106.21M

SMA 2017.30

SMA 5022.83

SMA 20024.73

Price vs 50-35.31%

Price vs 200-40.27%

MA stackbearish

50/200 crossdeath · 6d

Supertrenddown · 17.28

RSI (14)32

MACD hist0.24

MACD crossbull · 2d

Stoch %K / %D60 / 48

ADX (14)31

+DI / −DI23 / 36

RSI divergence—

MACD divergence—

ATR %9.00%

ADR %5.39%

52w high36.54

52w low12.88

From 52w high-59.58%

Above 52w low+14.67%

New 52w highNo

SqueezeOff

Bollinger width115.68%

%B0.37

Donchian pos14.50%

Donchian high26.80

Donchian low12.73

AVWAP (52w high)22.90

vs AVWAP high-35.49%

AVWAP (52w low)14.49

vs AVWAP low+1.95%

OBV trendFlat

Chaikin MF (20)0.10

Today vs 20d0.52×

Avg vol (14d)6.7M

Avg vol (20d)6.74M

Avg $ vol (20d)106.21M

Market cap1.46B

RS Rating10 / 99

RS 3m (vs SPY)-54.00%

RS 6m (vs SPY)-42.41%

RS line new highNo

Trend template0/8

Technical rank11.9

1 week+1.86%

1 month-44.18%

3 months-49.50%

6 months-25.59%

1 year-47.99%

YTD-37.42%

P/E-2.53

P/B-5.00

P/S2.16

P/FCF-3.09

EPS-5.83

Div yield—

ROE197.59%

ROA-45.49%

Debt/Eq—

Current1.73

EV/EBITDA-2.66

Gross margin—

Net margin-85.44%

Rev growth20.18%

EPS growth-1.05%

Price target28.47

Target upside92.76%

Analyst ratingBuy

Institutional120.14%

Ent. value1.33B

Revenue214M

Net income-92M

Gross profit—

Free cash flow-472M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out98.49M

Employees1.37K

ListedFri, Jan 31, 2014

Free float91.5M

Float %94.9%

Short interest17.14M

Days to cover8.0d

Short volume26.8%

Squeeze score62 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.90 vs −$1.27

Last surprise+29.1% beat

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank11.9 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance28.49

Support13.27

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in RARE · 3 recent

All disclosures →

Member	Side	Amount	Traded	Filed	PTR
Gilbert Cisneros house · CA · traded 2026-03-03	Buy	$1K–$15K	2026-03-03	2026-04-06	PDF
Gilbert Cisneros house · D · CA · traded 2025-08-08	Buy	$1K–$15K	2025-08-08	2025-09-12	PDF
Gilbert Cisneros house · D · CA · traded 2025-07-15	Buy	$1K–$15K	2025-07-15	2025-08-14	PDF

Insider activity

SEC Form 4 transactions in RARE · open-market 3 sells

Insider	Side	Shares	Value	Traded	Filed
Huizenga Theodore Alan SVP, Chief Accounting Officer · Common Stock · 2026-09-15	Sell	1.28K	$17K	2026-09-15	2026-09-15
Horn Howard Chief Financial Officer · Common Stock · 2026-06-01	Sell	4.65K	$111K	2026-06-01	2026-06-01
SULIMAN SHEHNAAZ Director · Common Stock · 2026-05-18	Sell	5.74K	$144K	2026-05-18	2026-05-18
Dunsire Deborah Director · Common Stock · 2026-05-14	Grant	7.75K	$0	2026-05-14	2026-05-18
Sanders Corazon (Corsee) D. Director · Common Stock · 2026-05-14	Grant	7.75K	$0	2026-05-14	2026-05-18
Fust Matthew K Director · Stock Option (Right to Buy) · 2026-05-14	Grant	14.06K	$0	2026-05-14	2026-05-18
Ray Amrit Director · Common Stock · 2026-05-14	Grant	7.75K	$0	2026-05-14	2026-05-18
Fust Matthew K Director · Common Stock · 2026-05-14	Grant	7.75K	$0	2026-05-14	2026-05-18
WELCH DANIEL G Director · Stock Option (Right to Buy) · 2026-05-14	Grant	14.06K	$0	2026-05-14	2026-05-18
NARACHI MICHAEL Director · Common Stock · 2026-05-14	Grant	7.75K	$0	2026-05-14	2026-05-18

SEC filings

EDGAR filings in RARE · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.